You do assume that the takeover will proceed. Another concern is that if this is now great value, where is the director buying?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025